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Editorial on the Research Topic
Emerging Roles of TRP Channels in Brain Pathology
The mammalian transient receptor potential (TRP) ion channel superfamily comprises six
subfamilies, TRPC (canonical), TRPV (vanilloid), TRPM (melastatin), TRPA (ankyrin), TRPP
(polycystin), and TRPML (mucolipin) (Ramsey et al., 2006; Venkatachalam and Montell, 2007).
TRP channels are tetrameric and each subunit contains intracellular N- and C-termini and six
membrane-spanning segments, with the fifth and sixth segments and the re-entrant loop between
them forming the ion-conducting pore (Cao, 2020). They function as non-selective cation channels,
with prominent Ca2+ permeability formost of them, and are activated by diverse physical, chemical
and biological stimuli. Their Ca2+ permeability, poly-modal activation and wide expression place
these channels in a vital position mediating Ca2+ signalling in a range of physiological processes.
Not surprisingly, accumulating evidence supports an important role for the TRP channels in the
pathogenesis of numerous diseases (Nilius et al., 2007). Many TRP channels are expressed in the
brain. This Research Topic, including 14 review and original research articles, offers critical and
new insights into the role of TRP channels, particularly the Ca2+-permeable ones, in multiple
brain pathologies.
TRPC IN ISCHEMIC BRAIN DAMAGE
Brain is highly vulnerable to damage by ischemia, if severe or lasting, and reperfusion after
transient ischemia. Jeon et al. have critically evaluated the literature and also presented their
recent study regarding the role of TRPC channels in ischemic brain damage. A complex role
for the TRPC channels is emerging from studies, using middle carotid artery occlusion followed
by reperfusion (MCAO/R), an in vivo model of ischemic stroke, and neuronal death induced
by oxygen and glucose deprivation followed by reoxygenation (OGD/R), an in vitro model of
ischemia/reperfusion, in combination with using transgenic knockout (KO) mice and neurons
or brain slices derived from KO mice or using pharmacological interventions. TRPC channels,
including TRPC3, TRPC4, TRPC6, and TRPC7, play a significant role in mediating ischemic brain
damage. TRPC1 was proposed to act as a protective mechanism against ischemic brain damage
via inhibiting generation of reactive oxygen species (ROS). However, Jeon et al. showed that
TRPC1-KO attenuated OGD/R-induced neuronal death.
Neuroinflammation is another mechanism for ischemic brain damage and many other brain
pathologies. Liu et al. showed that inhibition or depletion of TRPC6 suppressed OGD/R-induced
Ca2+ response, production of interleukin (IL)-1β and IL-6, two neurotoxic proinflammatory
cytokines, caspase-3 activation and apoptosis in astrocytes. Inhibition of TRPC6 also attenuated
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MCAO/R-induced caspase-3 activation, elevated level of IL-
1β and IL-6 in the peri-infarct areas, and infarction in mice.
These results support a critical role for TRPC6 in astrocytes in
mediating neuroinflammation and ischemic brain damage.
TRP IN NEURODEGENERATIVE AND
NEUROLOGICAL DISEASES
Alzheimer’s disease (AD), Parkinson’s diseases (PD),
Huntington’s disease, amyotrophic lateral sclerosis and epilepsy
represent the most common neurodegenerative and neurological
diseases. Extensive research efforts have been devoted to
exploring the TRP channels in the pathogenesis of these
conditions. Lee et al. have provided a concise overview of the
potential involvement of the TRP channels in AD (TRPC1,
TRPC6, TRPV, TRPM2, TRPM7, and TRPML1), PD (TRPC1,
TRPC4, TRPC5, TRPM7, and TRPML1), Huntington’s disease
(TRPC1 and TRPC5), amyotrophic lateral sclerosis (TRPC4,
TRPM2, TRPM3, TRPM7, and TRPML1) and epilepsy (TRPC4,
TRPC5, TRPV4, TRPM7, and TRPA1). They further elaborated
diverse TRP-mediated Ca2+-dependent downstream signalling
pathways to the associated pathologies. Vaidya and Sharma
have drawn their attention to the TRP channels expressed in
substantial nigra pars compacta and other brain areas affected
in PD. TRPC1 was shown to protect PD-related neuronal
death. Intriguingly, both activation and inhibition of TRPV1,
reported by different studies, improved motor function through
regulation of distinctive molecular and cellular mechanisms.
Oxidative stress, due to accumulation of high levels of ROS,
is a pathological factor as well as a conspicuous pathological
feature in PD (Prasad and Hung, 2020). Vaidya and Sharma
also discussed the role of TRPM2 and TRPM7, both known
to be sensitive to activation by ROS, in mediating PD-related
neuronal death.
TRPV IN BBB DYSFUNCTION AND
RELATED BRAIN PATHOLOGIES
Endothelial cells play a key role in forming blood brain barrier
(BBB), and BBB dysfunction results in infiltration of peripheral
immune cells into the brain to exacerbate neuroinflammation
and thereby ischemic stroke and neurodegenerative diseases
(Sweeney et al., 2018). TRPV4 is known to regulate endothelial
barrier function via mediating Ca2+ influx into endothelial
cells. Consistently, Rosenkranz et al. demonstrated that
pharmacological inhibition of TRPV4 in mouse brain
microvascular endothelial cells improved endothelial barrier
function. Such an effect was however obliterated in endothelial
cells after exposure to interferon-γ and tumour necrosis factor-α
that down-regulated the TRPV4 expression. In mice, TRPV4-KO
failed to prevent BBB dysfunction and associated experimental
autoimmune encephalomyelitis, a model of multiple sclerosis,
or MCAO/R-induced brain damage, suggesting loss of TRPV4-
mediated regulation of BBB function under inflammation. Luo
et al. examined and revealed a different profile of TRPV1-4
expression in brain endothelial cells of rat and human origins,
ranking from high to low: TRPV4 > TRPV2 > TRPV3 >
TRPV1 in rat endothelial cells, and TRPV2 >> TRPV4 >
TRPV1 > TRPV3 in human endothelial cells. Thus, TRPV4 and
TRPV2 represent the predominant TRPV in human and rat
brain endothelial cells, respectively. Such species difference may
complicate testing drugs using rat models of BBB dysfunction
and related brain pathologies.
TRPM3 IN DEVELOPMENTAL DISORDERS
TRPM3 is activated by endogenous neurosteroid pregnenolone
sulphate. TRPM3 expression is documented in several brain
regions, including hippocampus and choroid plexus, and in
cerebellar Purkinje neurons and oligodendrocytes. Held and
Tóth have reviewed the potential role of TRPM3 in brain
physiological and pathophysiological functions, and highlighted
genetic alterations in the TRPM3 gene in patients with
development and intellectual disabilities. Particularly interesting
is the identification of de novo gain-of-function mutations in
patients with developmental and epileptic encephalopathies.
Deletions in the TRPM3 gene were found in patients with
Kabuki syndrome, a multisystem disorder including intellectual
disability, and in autism patients. However, it remains unclear
how alteration of TRPM3 affects brain development and
other functions.
TRP IN PSYCHIATRIC DISORDERS
Psychiatric disorders such as depression and anxiety disorders
are caused by diverse and complex factors, both genetic and
environmental. As proposed in neurodegenerative diseases,
oxidative stress is a critical pathological factor, and Ca2+
signalling is disrupted, in psychiatric disorders. Nakao et al.
have overviewed the redox-sensitive Ca2+-permeable TRP
channels in neurons and glial cells, including TRPC4, TRPC5,
TRPV1, TRPM2, and TRPA1, in regulating cell functions.
They have provided a concise summary of the studies that
showed using a battery of behaviour tests that anxiety-like
behaviours in mice were attenuated by genetic deletion (TRPC4,
TRPC5, TRPV1, TRPM2, or TRPA1) or pharmacological
inhibition (TRPC4/TRPC5). They also discussed the possible
mechanisms by which these channels mediate oxidative stress-
induced Ca2+ signalling and subsequent alterations in neuronal
connectivity, synaptic plasticity and glial cell function, leading to
psychiatric disorders.
TRP IN CHRONIC PAIN AND ITS
INHIBITION BY RESOLVINS
Chronic pain occurs as a result of neuronal tissue inflammation
and/or damage. Increased expression and/or activation of TRP
channels in nociceptive neurons can enhance the excitability
of nociceptive neurons and thereby intensify the pain signals.
Resolvins are a class of lipid mediators generated during the
resolution phase of acute inflammation. Roh et al. discussed the
studies showing analgesic effects of different resolvins against
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inflammatory pain, through activating distinct cognate receptors
to inhibit nociceptive TRP channels, including TRPV1, TRPV3,
TRPV4, and TRPA1. The role of such inhibitory mechanisms in
neuropathic pain is unknown.
TRP IN BRAIN TUMOURS
Malignant glioma including glioblastoma is the most common
group of primary brain tumours and exhibits resistance to
treatment and high recurrence. Chinigò et al. have conveyed the
literature informing the expression of TRP channels and their
potential role in brain tumours. The expression in glioma tissues
and cells was shown to be upregulated (TRPC1, TRPC6, TRPV4,
TRPM2, TRPM7, TRPM8, and TRPML2), or down-regulated
(TRPV1, TRPV2, and TRPML1). Such alterations in some
cases exhibited correlations with glioma progression and overall
patient survival. Moreover, some of these channels (TRPC1,
TRPC6, TRPV4, TRPM7, TRPM8, and TRPML2) appear pro-
tumorigenic and, conversely, others (TRPV1, TRPV2, TRPM2,
TRPM3, TRPA1, and TRPML1) are anti-tumorigenic. Chinigò
et al. have proposed diverse signalling pathways, downstream
of TRP channel-mediated elevation in intracellular Ca2+, in the
regulation of glioma cell proliferation, migration and invasion as
well as cell death.
TRP IN REGULATING Ca2+ AND H+
HOMEOSTASIS AND INTERACTING WITH
OTHER SIGNALLING MECHANISMS
Disruption in Ca2+ homeostasis has been alluded by multiple
articles as an important mechanism in the pathogenesis of
brain pathologies. Plasma membrane Ca2+-ATPase drives Ca2+
efflux and H+ influx and thus plays a vital role in modulating
intracellular Ca2+ and H+ homeostasis. Hwang et al. have
reviewed the role in neurodegenerative diseases of the plasma
membrane Ca2+-ATPase in concerted actions with Ca2+-
permeable TRP channels in altering Ca2+ and H+ homeostasis
in neuronal and glial cells.
Hermann et al. investigated contribution of dinucleotide
nicotinic acid adenine phosphate (NAADP)-induced Ca2+
release in mouse hippocampal neurons to the Ca2+ response
evoked by glutamate, the major excitatory neurotransmitter
in the brain. They proposed that NAADP induces Ca2+
release from intracellular acidic stores by activating TRPML1
and two-pore channels, and also from ER by activating
ryanodine receptors, and showed that inhibition of NAADP
signalling reduced glutamate-evoked Ca2+ response, particularly
the sustained component. The study demonstrated substantial
contribution of NAADP to glutamate-induced Ca2+ signalling in
hippocampal neurons.
The activity of small Rho GTPases is critical for actin-based
cytoskeletal remodelling. Ca2+ is an intracellular signal upstream
of Rho GTPases. Lavanderos et al. have introduced the role
of Rho GTPases in the regulation of axon growth, dendritic
spine development, synapse formation, glial cell migration, and
endothelial permeability, which are vital in sustaining brain
structure and function. They further presented the potential Rho
GTPase-dependent mechanisms that mediate Ca2+-permeable
TRP channels in various brain conditions, including AD (TRPC6
and TRPV1), ischemic bran damage (TRPM7), glioma and
neuroblastoma (TRPC6, TRPV1, TRPM7, and TRPM8).
Manchanda et al. extended their previous work to study
TRPV1 in regulating the generation of endocannabinoids.
Treatment of human embryonic kidney 293 cells expressing
TRPV1 with capsaicin increased the levels of 2-acyl glycerols
and reduced the levels of N-acyl ethanolamines, depending upon
temperature. These results support the interesting notion that
the TRPV1 and the receptor for endocannabinoids cross-talk in
response to changes in temperature.
Collectively, the insightful evaluation of the literature and
the new information presented in this Research Topic have
evolved a better understanding of the TRP channels in the
pathogenesis of multiple brain pathologies, and also raised
many outstanding questions that need further researches in
order to gain comprehensive and mechanistic insights into
these pathological conditions and provide the proof of concept
of targeting the TRP channels and/or related mechanisms as
potential therapeutic strategies.
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